“HPV vaccination and allocative efficiency: regional analysis of the costs and benefits with the bivalent AS04-adjuvanted vaccine, from the perspective of public health, for the prevention of cervical cancer and its pre-cancerous lesions”, FE, vol. 13, no. 2S, pp. 3–15, Nov. 2012, doi: 10.7175/fe.v13i2S.449.